News View all news
AstraZeneca diabetes drug cuts heart risks in major study
AstraZeneca's diabetes drug dapagliflozin (Farxiga) met a key goal in a major clinical study designed to show its heart-protecting benefits in a wide range of patients. The cardiovascular (CV) profile of medicines to treat diabetes is an important focus for doctors and patients.
Rivaroxaban for thromboprophylaxis after hospitalization for medical illness
Researchers investigated the effect of post-discharge thromboprophylaxis in patients hospitalized for a medical illness but still at risk for venous thromboembolism upon release. The MARINER clinical trial randomized high-risk patients to a 45-day course of rivaroxaban or to placebo.
September 18, 2018
Our thoughts to those affected by Florence, our thanks to the…
Heavy rain from Tropical Depression Florence is pounding the Carolinas, southwest Virginia, and southern West Virginia. Tragically, as of this writing, 32 people have lost their lives. Countless more…0 comments
August 22, 2018
APhA Financial Chief Joe Janela Named 2018 Nonprofit CFO of the Year
The American Pharmacists Association (APhA) announced today that Chief Financial Officer and Senior Vice President, Finance and Administration, Joseph Janela was named the 2018 Nonprofit CFO of the Year.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.